Juvenile myoclonic epilepsy (JME) is characterized by myoclonic jerks on awakening, generalized tonic-clonic seizures (GTCS) and is associated with absence seizures in more than one third of cases. Fifteen patients with juvenile myoclonic epilepsy were studied with regard to their clinical profile, EEG data and sleep EEG findings. There was a delay in the diagnosis of JME (mean of 3.5 years) due to various reasons. Sleep deprivation was the most common precipitating factor for triggering seizures, followed by fatigue. Routine EEGs were abnormal in 73.33% of cases only and had misleading findings in 6.66%. Sleep EEGs were abnormal in 100% of cases with generalized spikes, polyspikes and slow wave discharges. Discharge rates on sleep EEGs typically increased significantly during the transition phase (i.e. the asleep to awakening stage) and we consider this to be a specific finding in appropriate clinical setting. Sleep EEGs are a more sensitive and specific tool for the diagnosis of JME while routine awake EEGs may miss or mislead.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is an idiopathic generalized epileptic syndrome, which has age related onset. It is characterized by myoclonic jerks on awakening, generalized tonic-clonic seizures (GTCS) and is associated with absence seizures in more than one third of cases. Herpin 1 first described JME in 1867 from observation of a doctor's son. Few claim that interictal electroencephalograms (EEGs) can easily distinguish JME from other forms of generalized epilepsies because faster (3.5-6 Hz) spike waves and multispike wave complexes are always present 2 . However EEGs are not always diagnostic. Janz 3 found classical spike waves in 12% and various other abnormalities in cases of JME and concluded that rapid spike waves or the double spike wave complexes are not specific for JME. Salas et al. 4 conducted a study in Spain using polygraphic tracing of sleep during a nap period and documented that sleep EEGs were abnormal in all the patients. Ercegovac 5 found that EEG recordings during sleep confirmed the diagnosis in 100% of cases.
Thus routine EEGs are often nonspecific or misleading in JME. Hence other modalities such as prolonged EEG recordings, sleep EEG recordings, etc. are being tried. Nocturnal sleep EEGs are expected to provide more definitive changes as they would record the EEG for longer periods and also the transition from the awake to asleep state, all stages of sleep, during the process of awakening and finally the awake EEG. Sleep EEGs are a relatively new investigation and are only available at a few centers in India. Hence there is a scarcity of sleep EEG data. Thus, we conducted this study to investigate clinical patterns, sleep EEG patterns and EEG patterns during the transition from awake to asleep, as well as asleep to awake state in patients with JME.
MATERIALS AND METHODS
All patients presenting to the Departments of Neurology and Pediatrics, Dayanand Medical College and Hospital Ludhiana, India, between January 1998 and July 1999 with suspected epilepsy were evaluated and all of the fulfilling criteria for JME as de-scribed by Panayiotopoulous 6 were further studied. Detailed history, family history and thorough neurological examination were performed. Inclusion criteria for JME were: (a) unequivocal clinical evidence of generalized seizures with myoclonic jerks on awakening; (b) no evidence of neurological or intellectual deficit; and (c) normal brain imaging when performed. We excluded those with: (a) clinical or EEG evidence of myoclonic jerks secondary to brain hypoxia, metabolic disease or other structural brain abnormalities; (b) other generalized seizures without firm documentation of myoclonic jerks; and (c) EEG abnormalities, but no clinical evidence of any type of seizures. All the patients selected according to the abovementioned criteria were subjected to a sleep EEG recording using a digital EEG machine (MEDELAC DG EXAMINER). All the patients had at least one routine EEG before a sleep EEG was performed. Attempts were made to record the sleep EEG before starting treatment. However, if the patient was taking treatment, it was not stopped or changed before the procedure. During the EEG recording all precautions were taken not to alter the patient's sleep routine. The patients were dressed casually as per his/her routine, had his/her regular meals and went to bed 1 hour before his/her usual bedtime. The level of illumination in the room was kept as desired by the patient.
Recordings were performed using 16 channels for EEG, 2 channels for surface electromyogram (EMG) and 2 channels for electrooculography (EOG). Recordings were started at least half an hour before the patient's usual bedtime and continued throughout sleep and at least 1 hour after final awakening. Sleep stage scoring was done on an epoch by epoch basis, according to the guidelines of Rechtschaffen and Kales 7 . We used an epoch length of 30 seconds and a paper speed of 30 mm/s.
An awakening was scored when there was a return of the patient's waking background sustained for at least 30 seconds. The whole EEG was reviewed, scored and analyzed as for different stages of sleep and for spikes, polyspikes, sharp waves and slowing as per standard practice.
RESULTS
From January 1998 to July 1999, a clinical diagnosis of JME was made on 24 patients. However sleep EEGs could not be conducted on nine patients due to various reasons (usually refusal by the patient or parents) and these were excluded from the further analysis. The age ranged from 9 years to 20 years. Seven patients were male and eight were female. Mean age at diagnosis was 15.40 ± 3.247 years. The mean age of onset of first symptoms was 12.17 ± 3.513 years.
Only one patient came directly to us after a generalized seizure while the others were referred from different sources. Interestingly, none of the referred patients had been diagnosed with JME earlier. There was a delay on average of 3.5 years (range 6 months to 11 years) between the onset of the symptoms and the diagnosis of JME. Though the myoclonic jerks were present in all the cases, none of the referring doctors had elicited this history. Generalized tonic-clonic convulsions were present in all but one patient. This male patient was the brother of a patient with JME and had typical EEG findings, hence was included in the study. Absence seizures were present in 20% of patients and incidentally all of them were male. Thus myoclonic jerks alone were present in one patient (6.66%) while myoclonic jerks with GTCS were present in 11 (73.33%) and Myoclonic jerks, GTCS and absences were present in 3 (20%) of cases. None of the patients gave a history of photosensitivity. A family history of epilepsy could be elicited in 33.33% of cases. Sleep deprivation was the commonest factor for triggering seizures which was seen in 73.34% of cases while fatigue was responsible in 13.33% and no precipitating factor was found in 13.33% of cases. (Table 1.) Nine patients (60%) were not taking any treatment at the time of diagnosis, 20% were taking a combination of carbamazepine and valproate, 13.33% were taking carbamazepine alone while only one patient (6.66%) was taking valproate alone.
Routine awake EEGs were abnormal in 73.33% of cases and were normal in 26.66% while one (6.66%) had focal discharges leading to an initial diagnosis of focal epilepsy.
Sleep EEGs were abnormal in all cases with the presence of generalized epileptiform discharges. The discharges were characterized by spikes, polyspikes and slow wave discharges which were usually frontal predominant. 'Discharge rate' was calculated as the number of discharges per hour during different stages of sleep and during the awake period. 'Transition Phase' was defined as 1 hour prior to final awakening and half an hour after awakening.
Discharge rate in stage I was 22.08 ± 20.95, stage II was 24.42 ± 14.09, slow wave sleep was 9.83 ± 7.90 and transition phase was 61.75±44.17. Thus discharge rate increased significantly during the transition phase compared to stage I and II (P value < 0.05) as well as slow wave sleep (P value < 0.01).
DISCUSSION
Juvenile myoclonic epilepsy is a classical epileptic syndrome with age related onset. However the diagnosis is often delayed or missed due to various reasons including lack of familiarity with the syn- drome, failure to elicit a history of myoclonic jerking and variability in EEG characteristics 8, 9 . In our study we evaluated 15 patients with JME. Sex distribution was nearly equal. Mean age at diagnosis was 15.40 ± 3.247 years. The mean age of onset of first symptoms was 12.17 ± 3.513 years. Thus, there was a delay on average of 3.5 years (range 6 months to 11 years) between the onset of the first symptoms and a diagnosis of JME. A delay in diagnosis has also been found in several earlier studies. The mean delay in diagnosis was reported to be from 6.8 years to 14.5 years [8] [9] [10] [11] . The delay in diagnosis could be due to a lack of familiarity with the syndrome, failure to elicit a history of myoclonic jerking and variability in EEG results or their misinterpretation. In all of our patients there was a definite history of myoclonic jerks, which was not realized by the referring doctor and patients also ignored them as nervousness or an unrelated symptom. EEGs were normal in 26.66% of patients and showed focal discharges in 6.66%, adding further to the confusion in diagnosis. Myoclonic jerks were reported by all 15 patients (100%), generalized tonic-clonic seizures by 14 patients (93.33%) and absence seizures by 3 patients (20%). The triad of absence seizures, myoclonic jerks and GTCS was noted in 3 (20%) patients, 11 (73.33%) had myoclonic jerks and GTCS, one (6.66%) had only myoclonic jerks.
Asconape et al. 12 found that all the patients in their study had myoclonic jerks, 58% had myoclonic jerks and GTCS, and 25% had myoclonic jerks, GTCS and absence seizures. Neidzielska et al. 13 found that the typical attack triad occurred in 39%, GTCS and myoclonic seizures in 56% and in 5.6% only myoclonic seizures. Murthy et al. 11 found that absence seizures were reported by 20.6%, GTCS in 84.7%, and myoclonic jerks in 100%. They reported the triad of absence seizures, myoclonic jerks and GTCS in 17.5%, myoclonic jerks and GTCS in 67.2%, myoclonic jerks and absence seizures in 3% and only myoclonic jerks in 12.2% of patients. Our population was very similar to these studies.
In our study a family history of epilepsy was present in 5/15 (33.33%) cases. Similarly to earlier Indian studies, a family history was positive in 35% and 23% of cases in two series 11, 14 . We found that sleep deprivation was the commonest triggering factor for a seizure. It triggered seizures in 73.34% of cases. The next most important trigger was fatigue, which led to seizures in 13.33% of cases. In 13.33% of cases no precipitating factor was found. Thus precipitating factors could be traced in 86.66% of cases, the commonest being sleep deprivation. This finding was consistent with earlier studies. However none of our patients took alcohol so no inference concerning its possible effect as a seizure trigger could be made. There was no neurological deficit in any of the patients. CT heads were performed in four out of 15 cases, which were normal.
Awake EEGs were abnormal in 11 patients (73.33%) and normal in 4 (26.66%) patients. Generalized spikes, polyspikes and slow wave discharges were present in 81.81% of cases. Polyspike slow wave discharges were seen in 45.45% and 3-4 Hz spike wave discharges were seen in 27.27% of cases. Photoconvulsive responses were seen in 4/15 (26.66%) of cases. Focal discharges were seen in one patient (6.66%). Thus, routine awake EEGs either miss (26.66%) or mislead (6.66%) in a good number of cases.
Earlier workers have had similar experiences. Asconape 12 found that 50% of patients had normal EEGs at some point in their history. Obeid et al. 15 found that interictal EEGs were abnormal in 74% of patients. Panayiotopoulos et al. 16 found that at least one abnormal EEG was recorded in 84.9% of patients. Abnormalities consisted mainly of generalized discharges of spikes/double spikes and/or polyspikes and slow waves. Genton et al. 17 found that routine EEGs were normal in 27% of cases, misleading or nonspecific in 20% and showed typical changes in 54%. Others have also found that routine EEGs might miss the diagnosis in 22.22-23% of cases 5, 13 . Abnormalities in the remaining 77% of patients included generalized spike wave discharges in 73%, multiple spike wave complexes in 33%, and focal discharges in 12% of patients 5 . Indian authors have also reported generalized spike or multiple spikes slow wave paroxysms in 81% of initial EEG records, i.e. the initial EEG may miss the diagnosis 11 . In our study we also found that awake EEGs misdiagnosed in 26.66% of cases and misled in 6.66%. Thus routine awake EEGs were only able to correctly diagnose in two-thirds of the cases.
One out of 15 patients (6.66%) showed focal discharge on a routine awake EEG. Earlier studies have also shown focal abnormalities on routine EEGs, with a frequency ranging from 12-46% of patients 11, 15, 18 . Thus routine EEGs along with routine provoking procedures, i.e. hyperventilation and photic stimulation may not only misdiagnose, but even be misleading. Such an error could obviously lead to incorrect and/or inadequate treatment with serious consequences for the sufferer. Hence a more sensitive diagnostic modality is required. We expected that overnight sleep EEG recording would be a better diagnostic tool.
On studying the sleep EEGs of all 15 patients they were found to be abnormal in all cases, with generalized spikes, polyspike wave and spike wave discharges. In the last decade some authors have reported that sleep EEGs are always abnormal in JME, even when routine EEGs have been normal or showed misleading findings such as focal abnormalities 4, 5, 13 . Our study also found 73.33% of routine EEGs to be abnormal while 26.66% were normal but sleep EEGs were abnormal in 100% of cases and was diagnostic.
On studying the distribution of discharges in relation to various stages of sleep we found that discharges were significantly less in the slow wave stage (4.79 ± 4.63) as against stage I (25.21 ± 15.80) and stage II (29.01±15.61). Discharge rate during the transition phase was 61.75 ± 44.17. Thus discharge rate in the transition phase increased significantly compared to any other stage of sleep. The transition from the asleep to awake state caused an increase in discharge rate and the transition to slow wave sleep suppressed the number of discharges. JME is a circadian related syndrome and its clinical manifestations are strictly related to the sleep-awake cycle 3 . Final morning awakening and to a lesser extent nocturnal awakening and sleep onset activate myoclonic jerks. Conversely, sleep deactivates the epileptic phenomenon. Our findings of suppression of discharges during slow wave sleep could explain the deactivation of JME manifestations during sleep. The transition from the asleep to awake state causes a significant increase in the number of discharges and explains the presence of epileptiform abnormalities and occurrence of seizures after awakening. Our finding supports the hypothesis that bi-directional fluctuations of arousal play an important role in the appearance of generalized EEG epileptiform discharges 19 . The observations that JME epileptiform discharges occurring during sleep appear mainly during the 'dynamic periods' (i.e. during conditions of transition and instability) are not incompatible with the high degree of activation that occurs after nocturnal and final morning awakenings when a tendency to new sleep onset still exists.
The relationship between the sleep-awake cycle and the number of discharges on sleep EEGs in JME is apparently the opposite of that which occurs in other epilepsies. In general, NREM sleep enhances interictal discharges, e.g. 3 Hz. Spike slow wave bursts become increasingly frequent as the level of sleep deepens; the same holds true for spike slow waves of the LennoxGastaut syndrome. In benign Rolandic epilepsy the incidence of sharp waves rises by 400-500% in stages III and IV. In temporal lobe epilepsy maximal spike rates occur in stage I and II, declining in deeper levels. In contrast, in JME the incidence of bursts drops dramatically at the onset of stage II NREM sleep, remaining low during the deeper stages; however, enforced arousal produces abrupt increases to rates well above those of 'relaxed wakefulness' 20 . Thus sleep EEGs could be an important diagnostic tool for the diagnosis of JME.
On follow up of 11 out of 15 patients who were started on valproate (as per body weight), over a period ranging from 1 month to 1 1/2 year, nine out of 11 patients became seizure free. One patient stopped medication of his own volition and had seizures but on restarting treatment his seizures were controlled. One patient had a decreased number of seizures but was not completely asymptomatic. Thus we found that valproate is an effective anticonvulsant for managing patients with JME.
To conclude, a diagnosis of JME is often missed or delayed. A high degree of suspicion is required for an early diagnosis. Routine EEGs often miss or mislead diagnosis. Sleep EEGs are diagnostic and specific, and hence should be performed whenever JME is suspected or with difficult to control epilepsies or when clinical and routine EEG findings do not correlate.
